Novavax Inc.

NASDAQ: NVAX · Real-Time Price · USD
9.60
0.17 (1.80%)
At close: Aug 15, 2025, 3:45 PM

Novavax Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-187.5M -545.06M -657.94M -1.74B
Depreciation & Amortization
48.5M 41.23M 29.05M 12.66M
Stock-Based Compensation
48.15M 85.36M 130.3M 183.63M
Other Working Capital
67.11M 350.87M -1.05B 1.93B
Other Non-Cash Items
-44.89M 81.35M 443.8M 136.79M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
48.48M -376.84M -361.15M 1.73B
Operating Cash Flow
-87.26M -713.97M -415.94M 322.95M
Capital Expenditures
-13.06M -58.81M -92.98M -57.49M
Cash Acquisitions
n/a n/a n/a 57.49M
Purchase of Investments
-825.59M n/a n/a -2.17M
Sales Maturities Of Investments
443.55M n/a n/a 159.81M
Other Investing Acitivies
192.64M n/a -3.93M -57.49M
Investing Cash Flow
-204.04M -58.81M -92.98M 100.15M
Debt Repayment
-3.99M -352.35M 81.66M -127.91M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.3M -3.59M -5.9M 24.76M
Financial Cash Flow
260.58M 4.47M 324.99M 461.71M
Net Cash Flow
-38.52M -765.03M -179.41M 879.52M
Free Cash Flow
-100.32M -772.77M -508.92M 265.46M